]>
IRCT20101201005287N4 IRCT 2022-06-06 Tabriz University of Medical Sciences Spirulina in covid 19 Effect of Spirulina as a nutritional supplement and drug in Covid-19 patients 2021-12-10 anticipated 100 Complete https://irct.ir/trial/63341 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: From the patients who volunteered to participate in the study 100 people will be selected by simple random sampling. Randomization method: block Randomization unit:individual Random layers:In each block , people will be matched based on age and gender. Random Allocation tool:Random Allocation software. How to build a random sequence: Using Random Allocation software. Concealment: A random sequence created in a safe place and performed by an independent , non-independent person during the study, Blinding description: This study is a double-blind study that evaluates the consequences in this study and patients participating in the study will be unaware of the type of supplement received.Supplements will be provided to patients by another person who has no role in completing the questionnaire. Patient will also be informed of existence of two types of supplement (Spirulina and Placebo) when obtaining consent , but will be unaware of which study group they will be placed in. The capsules are exactly the same in shape, color and size and will smell the same due to their proximity for several days. 3 Covid19,Virus identified. Intervention 1: Intervention group: For 14 days ,patients received the Spirulina capsule(1g) prepared in Tabriz school of Pharmacy , while visiting the Imam Reza hospital from a researcher , consuming 4g daily with glass of water. Intervention 2: Control group: Control group: For 14 days ,patients received a starch capsule(500mg) prepared in Tabriz school of Pharmacy , while visiting the Imam Reza hospital from a researcher , consuming 4g daily with glass of water. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.
public Akbar Sharifi
Imam Reza Hospital,Golgasht Ave
Tabriz Iran (Islamic Republic of) 1566614766 +98 41 3371 5449 asharifi@tbzmrd.ac.ir Tabriz University of Medical Sciences scientific Akbar Sharifi
Imam Reza hospital,Golgasht Ave
Tabriz Iran (Islamic Republic of) 1566614766 +98 41 3317 5449 asharifi@tbzmrd.ac.ir Tabriz University of Medical Sciences Iran (Islamic Republic of) confirmation of Covid19 by PCR test satisfaction to participate in the study no limit no limit Both Having an underlying disease peregnancy stop taking the drug U07.1 COVID19 , Virus identified Placebo Placebo Intervention group: For 14 days ,patients received the Spirulina capsule(1g) prepared in Tabriz school of Pharmacy , while visiting the Imam Reza hospital from a researcher , consuming 4g daily with glass of water. Control group: Control group: For 14 days ,patients received a starch capsule(500mg) prepared in Tabriz school of Pharmacy , while visiting the Imam Reza hospital from a researcher , consuming 4g daily with glass of water. Interleukin-6 blood levels of patients before and after taking the drug. Timepoint: Before starting the drug and 14 days after taking the drug. Method of measurement: Blood sample analysisfor IL-6 by ELIZA in the labratory. Serum TNF-α levels in patients plasma. Timepoint: Before starting the drug and 14 days after starting the drug. Method of measurement: Blood sample analysis for TNF-α by ELIZA in the laboratory. Tabriz University of Medical Sciences Approved 2021-12-10 Ethics committee of Tabriz University of Medical Sciences Imam Reza hospital, Golgasht Ave Tabriz East Azarbaijan Iran (Islamic Republic of)